The addition of idarucizumab to plasma samples containing dabigatran allows the use of routine coagulation assays for the diagnosis of hemostasis disorders

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|11|2087-2092

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.11, 2015-11, pp. : 2087-2092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Idarucizumab for dabigatran overdose in a child

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 457-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 1, 2015-07 ,pp. : 137-141

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plasma D‐dimer assays in the diagnosis of venous thromboembolism in cancer patients

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 4, Iss. 1, 2006-01 ,pp. : 50-51

John Wiley & Sons Inc

Access to resources Recommend Favorite

Preanalytical aspects of routine coagulation measurements

By  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 2, 2001-04 ,pp. : 167-168

Informa Healthcare

Access to resources Recommend Favorite

Inherited disorders of blood coagulation

By Lippi Giuseppe   Franchini Massimo   Montagnana Martina   Favaloro Emmanuel J.  

Annals of Medicine, Vol. 44, Iss. 5, 2012-08 ,pp. : 405-418

Informa Healthcare

Access to resources Recommend Favorite